Eiger BioPharmaceuticals, Inc. (EIGR) Unrecognized Tax Benefits USD 2012 - 2023

Historical data

Taxonomy & unit: us-gaap: USD
Description: Amount of unrecognized tax benefits.
Summary: Eiger BioPharmaceuticals, Inc. quarterly Unrecognized Tax Benefits history and growth rate from 2012 to 2023.
Eiger BioPharmaceuticals, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $5.28 M, a 51.1% increase year-over-year.

Unrecognized Tax Benefits, Quarterly (USD)

Unrecognized Tax Benefits, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2023	$5.28 M	+$1.78 M	+51.1%	Dec 31, 2023	10-K	2024-04-08
Q4 2022	$3.49 M	+$1.54 M	+79.1%	Dec 31, 2022	10-K	2024-04-08
Q4 2021	$1.95 M	+$1.5 M	+332%	Dec 31, 2021	10-K	2024-04-08
Q4 2020	$451 K	-$2.83 M	-86.2%	Dec 31, 2020	10-K	2023-03-17
Q4 2019	$3.28 M	-$1.36 M	-29.3%	Dec 31, 2019	10-K	2023-03-17
Q4 2018	$4.63 M	+$1.42 M	+44%	Dec 31, 2018	10-K	2022-03-10
Q4 2017	$3.22 M	+$1.39 M	+75.8%	Dec 31, 2017	10-K	2021-03-09
Q4 2016	$1.83 M	+$1.43 M	+353%	Dec 31, 2016	10-K	2020-03-13
Q4 2015	$404 K	+$305 K	+308%	Dec 31, 2015	10-K	2019-03-14
Q4 2014	$99 K	+$2 K	+2.06%	Dec 31, 2014	10-K	2018-03-09
Q4 2013	$97 K	+$2 K	+2.11%	Dec 31, 2013	10-K	2017-03-23
Q4 2012	$95 K			Dec 31, 2012	8-K/A	2016-06-17

* An asterisk sign (*) next to the value indicates that the value is likely invalid.